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Oligodendrocytes (OLGs) are generated late in development and myelination is thus
a tardive event in the brain developmental process. It is however maintained whole
life long at lower rate, and myelin sheath is crucial for proper signal transmission and
neuronal survival. Unfortunately, OLGs present a high susceptibility to oxidative stress,
thus demyelination often takes place secondary to diverse brain lesions or pathologies.
OLGs can also be the target of immune attacks, leading to primary demyelination lesions.
Following oligodendrocytic death, spontaneous remyelination may occur to a certain
extent. In this review, we will mainly focus on the adult brain and on the two main sources
of progenitor cells that contribute to oligodendrogenesis: parenchymal oligodendrocyte
precursor cells (OPCs) and subventricular zone (SVZ)-derived progenitors. We will shortly
come back on the main steps of oligodendrogenesis in the postnatal and adult brain, and
summarize the key factors involved in the determination of oligodendrocytic fate. We will
then shed light on the main causes of demyelination in the adult brain and present the
animal models that have been developed to get insight on the demyelination/remyelination
process. Finally, we will synthetize the results of studies searching for factors able to
modulate spontaneous myelin repair.
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ORIGIN AND FATE OF OLIGODENDROCYTE PRECURSOR
CELLS
OLIGODENDROGENESIS FROM BIRTH TO ADULTHOOD
Generation of oligodendrocyte precursor cells during prenatal
development and their fate in adult brain parenchyma
OLGs are the last cells to be generated after neurons and astro-
cytes during development. In the developing forebrain, several
waves of OPC production and migration generate the entire OLG
population. At E12.5 in mice, a first ventral wave of OPC pro-
duction originates in the ganglionic eminence (Spassky et al.,
2001; Tekki-Kessaris et al., 2001). As development progresses, a
second and third wave of OPCs emanating from the lateral and
caudal ganglionic eminences at E15.5 and from the cortex after
birth, respectively, give rise to the majority of adult OLGs in mice
(Kessaris et al., 2006). These OPCs spread to populate most of the
future brain. Recent evidences have suggested that various waves
of OPCs could myelinate distinct regions of the brain, suggesting
the existence of distinct functional subpopulations of progeni-
tors which could fulfill different functions (Tripathi et al., 2011).
Interestingly in the brain as in the spinal cord, when any of these
populations from different origins is ablated, neighboring pop-
ulations quickly expand to generate the normal number of OLGs
in the mature brain (Kessaris et al., 2006). These experiments sug-
gest that OPCs compete during development and are functionally
equivalent.
The OPCs generated during development in restricted areas
have an amazing migration capacity and populate the brain and
spinal cord to generate OLGs and myelinate the entire CNS dur-
ing the postnatal life. A small fraction of OPCs generated during
development are maintained as an immature slowly proliferative
or quiescent state in the adult CNS (Dawson et al., 2003). These
adult OPCs are present in all brain structures and represent 2–9%
of the CNS cell population (Dawson et al., 2003). OPCs density
does not perceptibly vary during adulthood but is higher in white
matter than in graymatter (Dimou et al., 2008; Rivers et al., 2008).
This difference is in part due to the higher rate of proliferation of
OPCs in the white matter (Dimou et al., 2008). Notably gray and
white matter OPCs also differ by their ability to differentiate into
mature oligodendrocytes. While OPCs in white matter are pro-
liferative and contribute to adult oligodendrogenesis, gray matter
OPCs are quiescent or slowly proliferative and most remain in an
immature state (Dimou et al., 2008).
Current evidence suggests that adult OPCs express the same
markers as their developmental counterparts and appear mor-
phologically similar (Franklin and Ffrench-Constant, 2008).
Various markers are used to specifically identify adult OPCs,
including the proteoglycan NG2 (Nishiyama et al., 1999) and the
platelet derived growth factor receptor α (PDGFRα). They also
express other markers such as the O4 antigen and the transcrip-
tion factors Olig2, Olig1, and Nkx2.2 (Fancy et al., 2004). Since
some of these markers can also be expressed by other cell pop-
ulations (including synantocytes and endothelial cells of blood
vessels) or alternatively maintained in later stages of OLGmatura-
tion, a combination ofmarkers is often suitable to unambiguously
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identify OPCs in the adult CNS. But adult OPCs also differ from
their developmental counterparts in some ways including growth
factor responsiveness, migration capacities and longer cell cycle
time (Wolswijk and Noble, 1989; Wren et al., 1992; Psachoulia
et al., 2009). In the adult brain, half of the OPCs are cycling
in physiological condition (average period of around 1 week)
while the remaining OPCs are quiescent or divide more slowly
(Rivers et al., 2008). This suggests that adult OPCs could repre-
sent a heterogeneous population with possible distinct functions.
Various studies have demonstrated that gray and white matter
OPCs have differing resting membrane potentials and ion chan-
nel expression profiles (Yuan et al., 2002; Karadottir et al., 2008).
Two classes of OPCs have been identified in the adult brain:
one lacking voltage-gated Na+ channels completely, whereas the
other expresses voltage-gated Na+ current and generates trains
of action potentials. OPCs that generate action potentials are
capable of sensing the neuronal activity in the environment by
receiving synaptic inputs from axons and are more sensitive to
ischemia (Karadottir et al., 2008).
Other studies have suggested that OPCs properties could be in
part due to environmental cues. For example many reports have
illustrated differences in proliferation and differentiation capac-
ity of OPCs depending on brain areas. A recent study has shown
that OPCs from white matter can efficiently differentiate into
myelinating oligodendrocytes independent of the area they were
transplanted in while OPCs purified from gray matter do so less
efficiently (Vigano et al., 2013). The gray matter has been shown
to decrease OPC proliferation and to arrest OLG differentiation
while white matter environment maintains division and favors
OLG maturation (Dawson et al., 2000; Dimou et al., 2008; Rivers
et al., 2008).
Oligodendrogenesis in postnatal subventricular zone
After birth and in the adult brain, OPCs are continually pro-
duced by adult NSCs located in the SVZ (Menn et al., 2006). SVZ
stem cells generate fast dividing transient amplifying cells (C cells)
which in turn generate neuronal progenitors migrating toward
the olfactory bulb (OB) and differentiating as interneurons (Lois
and Alvarez-Buylla, 1993; Doetsch et al., 1999). Neuronal pro-
genitors migrate tangentially along the rostral migratory steam
(RMS), a well-defined pathway from the SVZ toward the OB
(Kirschenbaum et al., 1999). A small fraction of C cells generate
OPCs which migrate radially out of the SVZ into the overlying
whitematter and cortex, (Suzuki andGoldman, 2003;Menn et al.,
2006) for review see (Cayre et al., 2009). A recent analysis using
live imaging and single-cell tracking technologies in the SVZ has
shown that a single NSC exclusively generates OLGs or neurons,
but never both (Ortega et al., 2013). The number of OLGs formed
is consistently lower compared with the number of neurons that
migrate and differentiate in the OB (Menn et al., 2006). The
ratio of OLG/neuron production is dependent on the dorsoven-
tral and rostrocaudal levels in the SVZ. In the adult brain where
this aspect has been extensively studied, more OLGs are produced
from the dorsal part of the SVZ (facing the corpus callosum) than
from the ventrolateral part of the structure (facing the striatum)
(Ortega et al., 2013). Furthermore, along the rostrocaudal axis of
the brain, a higher number of OLGs are produced in the posterior
part of the SVZ (1 OLG/3 neurons) compared to rostral SVZ (1
OLG/30 neurons) (Menn et al., 2006). This regionalization of the
SVZ for OLG production is under the influence of environmen-
tal factors including Wnt dorsally (Ortega et al., 2013) and BMP
ventrally (Colak et al., 2008) respectively favoring and inhibiting
OPC specification in the adult brain. The OLG/neuron ratio also
changes depending on the age of the animal: while the number
of OPCs produced in the SVZ after birth is important leading to
numerous and active production of OLGs in the corpus callosum
and cortex, this number is drastically reduced in the adult brain.
Then, in the aging brain, this low level of oligodendrogenesis is
maintained while neuron production in the OB is compromised
and RMS cytoarchitecture altered (Capilla-Gonzalez et al., 2013).
Oligodendrocyte determination
Extrinsic factors. The relative intensity of Shh, BMP and Wnt/β-
catenin signals during development is a critical determinant of
oligodendrogenesis. In the spinal cord OPC commitment and
production is tightly regulated by these patterning molecules
inducing the expression of specific sets of transcription factors
along the dorso-ventral axis. The pMN domain marked by the
Olig2 expression first generates motor neurons and then pro-
duce most of the OPCs. This switch is tightly dependent on the
dose of Shh (Dessaud et al., 2010) regulated by heparan sulfate
dependent gradient formation (Touahri et al., 2012) and by the
Notch/delta pathway limiting the number of motoneurons pro-
duced and allowing OLG commitment (Kim et al., 2008). The
dorsalizing factors, BMPs and Wnt also regulate this decision
by repressing the OPC fate (See and Grinspan, 2009). The neu-
roglial switch in the pMN induces the expression of specific genes
involved in OPC determination. Although Olig2 is expressed in
motoneuron precursors in the pMN, its expression is down reg-
ulated in differentiating neurons and then this factor becomes
specific to oligodendrocytic lineage.
The same molecular cues act in the brain, where the pres-
ence of Shh induces the formation of ventrally derived OPCs in
the forebrain (Tekki-Kessaris et al., 2001). The dorsally expressed
Wnt/β-catenin and BMP pathways antagonize the effect of Shh.
In opposite to the inhibitory effect of Wnt in the spinal cord
(Shimizu et al., 2005), Wnt3 a factor belonging to the same fam-
ily plays a crucial role in promoting OLG specification in the adult
SVZ (Ortega et al., 2013).
In the adult brain, the germinal niche (i.e., SVZ) possesses spe-
cialized properties regulating stem cell proliferation and commit-
ment toward specific lineages (Ihrie and Alvarez-Buylla, 2011).
In particular, numerous extrinsic cues secreted by blood vessels
or associated to the extracellular matrix have been described in
the niche to favor OLG formation in physiological conditions.
For example, endothelial cells of the blood vessels have the capac-
ity to promote OPC commitment (Chintawar et al., 2009; Plane
et al., 2010). This effect is mediated in culture by the produc-
tion of specific chemokines including MCP1 (Chintawar et al.,
2009). Among components of the extracellular matrix that could
regulate OLG production, laminin plays a crucial role (Relucio
et al., 2012). Mice lacking laminin α2-subunit show a reduction
in the number of OPCs produced in the SVZ and present in the
adjacent corpus callosum (Relucio et al., 2012). The presence in
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the area of heparan sulfate (Liu and Casaccia, 2010; Mercier and
Arikawa-Hirasawa, 2012) could also suggest an important role of
proteoglycans in the regulation of morphogene and/or trophic
factor activity (Hacker et al., 2005). Most trophic factors present
in the SVZ, such as PDGF (Jackson et al., 2006) and EGF (Aguirre
et al., 2007), regulate OPC proliferation and/or maturation but
do not directly act on OLG determination in this area.
Transcription factors and epigenetic. Besides these environmen-
tal cues, which are important to define the domains that will
generate OLGs in CNS, cell commitment toward the OLG lineage
is regulated by the dynamic interaction between transcription fac-
tors and epigenetic factors including microRNA (miRNA) (Liu
and Casaccia, 2010).
Olig2. The best-defined transcription factor regulating OLG pro-
duction is the basic helix-loop-helix transcription factor Olig2
induced by ventrally secreted Shh in the spinal cord (Lu et al.,
2002). Olig2 is expressed throughout the oligodendrocyte lineage
from OPCs to myelinating oligodendrocytes. Olig2 inactivation
during development leads to a reduced production of OPCs in
most CNS regions (Lu et al., 2002; Zhou and Anderson, 2002;
Ligon et al., 2006) and induction of Olig2 expression in neu-
roepithelium leads to an increased generation of OPCs in the
CNS (Maire et al., 2010). Interesting data from Olig2-null mice
show that some OPCs are still generated in the hindbrain, most
likely through compensation by Olig1 (Lu et al., 2002). Olig2
is thus necessary and in some brain region sufficient for OPC
determination. After birth, Olig2 is restricted to few cells in the
SVZ representing a subpopulation of C cells which will be com-
mitted to the OLG lineage and migrate to the corpus callosum
and cortex (Menn et al., 2006). In the SVZ, Olig2 promotes
oligodendrogenesis by opposing Pax6 function that favors neu-
ronal progenitors generation (Hack et al., 2005). In addition, the
interactions between Olig2 and inhibitor of differentiation (ID)
family of helix-loop-helix transcriptional inhibitors mediate the
inhibitory effects of BMP4 on oligodendrogenesis (Samanta and
Kessler, 2004).
Ascl1/Mash1. The bHLH factor Ascl1/Mash1 plays an important
role in OLG specification. Ascl1 knockout mice show decreased
OPC generation in both the brain and spinal cord at early stages
(Parras et al., 2007; Sugimori et al., 2008). Nevertheless, rela-
tively normal numbers of OPCs are ultimately formed in these
mice may be due to the redundant function of Ascl2 and 3
also expressed in oligodendrocyte lineage in the developing CNS
(Sugimori et al., 2008). After birth, Ascl1 expression is restricted
to neural progenitors (C cells) and OPCs in the SVZ (Nakatani
et al., 2013). In this context, ablation of Ascl1 gene results in
a strong reduction of OLG production and leading to astrocyte
overproduction by SVZ progenitors (Nakatani et al., 2013). In the
adult brain, Ascl1 is required in oligodendrogenesis both under
normal physiological conditions and after demyelinating lesions.
A recent study reported that while Ascl1/Mash1 and Olig2 expres-
sion oscillate in neural progenitors, their stable expression is
observed during determination in neuronal and oligodendrocyte
progenitors respectively (Imayoshi et al., 2013).
Nkx and Sox families. Other transcription factors belonging to
the Homeobox and Sox family are also participating to oligo-
dendrogenesis, but loss of function analyses have shown a
non-essential or redundant role of these factors for OPC speci-
fication (Richardson et al., 2006). For example, motoneurons and
OLGs generated from the pMN domain are eliminated in the
Nkx6.1/Nkx6.2 double mutants demonstrating an essential role
for these factors during development (Cai et al., 2005; Vallstedt
et al., 2005). Among the sox gene family, Sox9, Sox8, and Sox10
are all expressed during OLG development. Mice lacking Sox9
have a reduced number of OLGs and astrocytes indicating a
requirement for this factor in general glial specification (Stolt
et al., 2003). Sox8/ Sox9 double inactivation leads to a complete
absence of OLGs suggesting a redundancy between the two fac-
tors (Stolt et al., 2003). Despite the fact that Sox10 is often used
as a specific marker for oligodendrocyte lineage cells, the loss of
this gene has no effect during determination but results in failure
in terminal cell differentiation (Stolt et al., 2004).
In summary, despite expression of numerous specific tran-
scription factors early during OPC determination most of them
such as Nkx2.2, Sox10, and Olig1 are not required for lineage
specification. Among all, Olig2 seems to be the only one abso-
lutely required for the specification of the lineage. In this context,
Olig2 is the only transcription factor absolutely required for direct
mouse fibroblast reprogramming (Najm et al., 2013; Yang et al.,
2013).
miRNA. miRNAs have been shown to play important roles in
both brain development and the regulation of adult neural cell
functions. Over the last few years, some specific miRNAs were
found to participate in the regulation of OLG differentiation and
myelin maintenance, as well as in the pathogenesis of demyelina-
tion diseases (for review see Liu and Casaccia, 2010; Li and Yao,
2012). Various studies have identified sets of miRNAs expressed
specifically by OLGs (Lau et al., 2008; Jovicic et al., 2013). Two
independent laboratories used targeted deletion of Dicer1 in
OLGs to disturb microRNA processing. They showed that pre-
venting miRNA processing disrupts normal brain myelination
despite an expansion of the OPC pool (Dugas et al., 2010; Zhao
et al., 2010). By contrast, miR-7a, one of the highly enriched
miRNAs in OPCs, promotes the generation of OPCs when over-
expressed in neural progenitors in vitro and in vivo during brain
development. Blocking the function of miR-7a in differentiating
neural progenitors led to a reduction of OPCs and an expansion
of neuronal progenitors (Zhao et al., 2012).
Histone modifications. Beside miRNA, other epigenetic mecha-
nisms including histone modifications can regulate OPC produc-
tion from NSCs (Liu and Casaccia, 2010). The activity of histone
deacetylases (Hdac) is for example important for OLG determi-
nation in the neonate SVZ. The ability of a stem cell to choose
alternative fate and to differentiate as OLG progenitors depends
on the activity of Hdac in vitro (Siebzehnrubl et al., 2007; Foti
et al., 2013). The involvement of histone methylation in the tran-
sition from stem cell to OPC is also suggested by evidence on
the role of Enhancer of zeste homolog 2 (Ezh2), a polycomb
group protein involved in gene silencing via histone methylation.
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Overexpression of Ezh2 increases the number of OLGs at the
expense of astrocytes, whereas its silencing produces opposite
effects (Sher et al., 2008).
Epigenetic regulation of OLG determination and maturation
is still a field to investigate and will provide in the future a better
understanding of oligodendrogenesis. It could offer new targets
for myelin repair (Liu and Casaccia, 2010).
OLIGODENDROCYTE PRECURSOR CELLS AND MYELIN PLASTICITY IN
ADULTHOOD
Oligodendrocyte precursor cells as multipotent stem cells
It has been suggested that adult OPCs may represent multipotent
stem cells in the adult brain. Purified OPCs in specific culture
conditions can be reverted to an immature NSC state: cells can
self-renew and give rise to neurons, astrocytes, and OLGs (Kondo
and Raff, 2000; Belachew et al., 2003). Nevertheless, in vivo
analysis showed that OPCs in the hippocampus generated pre-
dominantly OLGs, rarely neurons but never astrocytes (Belachew
et al., 2003). OPCs isolated from newborn mouse brain may
generate hippocampal neurons when transplanted into the SVZ
(Aguirre et al., 2004). These studies suggested that OPCs gener-
ated during the early postnatal life are multipotent in vitro and
can generate, beside OLGs, a small number of neurons in vivo.
Cre-Lox cell fate-mapping studies in mouse have recently entered
the debate. Genetic fate tracing using mice in which tamoxifen-
inducible Cre is expressed in OPCs has shown that while OPCs
generate both astrocytes and OLGs during development, in the
postnatal brain the capacity of these cells to generate astrocytes
is lost and adult OPCs produce exclusively OLGs (Dimou et al.,
2008; Rivers et al., 2008; Kang et al., 2010; Zhu et al., 2011).
Altogether these analyses confirm the idea that after birth OPCs
do not generate astrocytes. Rivers et al. (2008) reported the gen-
eration of a small subpopulation of neurons in the cortex but this
observation was due to pitfalls of the genetic fate mapping using
inducible Cre-recombinaison (Richardson et al., 2011; Clarke
et al., 2012). Although the multipotent capacity of OPCs is still
a matter of debate (Richardson et al., 2011), it seems most likely
that adult OPCs remain quiescent or slowly proliferative progeni-
tors and differentiate exclusively as myelinating OLGs in the adult
brain.
White matter plasticity in adulthood
One of themost striking advance in this field has been the demon-
stration that myelination perpetuates in the adult brain. The
use of inducible Cre-Lox fate mapping has allowed researchers
to genetically label OPCs in the adult brain and to follow their
progeny for a prolonged period of time and demonstrate their
capacity to myelinate continuously throughout normal adult life
(Dimou et al., 2008; Rivers et al., 2008). It is demonstrated that
20% of all OLGs in the adult mouse corpus callosum were gener-
ated after 7 weeks of age and that mature myelinating OLGs were
still generated until at least 8 months of age (Rivers et al., 2008).
A complementary analysis has shown that OLGs are still gener-
ated at a low rate after 8 month of age in mouse brain (Psachoulia
et al., 2009). Very little is known about the factors controlling
adult oligodendrogenesis. Physiological stimulus such as volon-
tary physical exercice can promote cell cycle exit and terminal
differentiation of adult OPCs (Simon et al., 2011). Interestingly,
a recent study demonstrated the impact of neuronal activity on
myelination in the adult brain (Gibson et al., 2014).
In humans magnetic resonance imaging showed that white
matter volume increases up to the age of 19 years (Giedd
and Rapoport, 2010) and that exercising complex skills such as
piano playing can further increase myelination (Bengtsson et al.,
2005).
Apart from the case of myelin repair which will be fur-
ther described below, one important issue now is to understand
what is the function of this constant production of myelinat-
ing OLGs over life in the brain. Myelination of fiber tracts is
not homogeneous in all structures (Sturrock, 1980; Dangata and
Kaufman, 1997). For example, the corpus callosum is known
to contain a mixture of myelinated and unmyelinated axons in
rodent (Sturrock, 1980) while the optic nerve is predominantly
composed of myelinated axons (Dangata and Kaufman, 1997).
Thus, newly form OLGs could be involved in the myelination
of naked axons in such structure or alternatively, new OLGs
could participate to a physiological turnover of myelin compart-
ment to replace dying OLGs in the entire brain. A recent study
(Young et al., 2013) has tackled this issue trying to distinguish
between these two hypotheses. Crelox fate mapping has demon-
strated that the number of newly formed OLGs is independent
of the level of myelination of the structure. OLG accumulation is
faster in the corpus callosum (contening a mixture of myelinated
and naked axons) than in the optic nerve (almost exclusively
formed of myelinated axons) but the overall production of long-
term-surviving OLGs over a 10 months period is similar in the
highly myelinated optic nerve and the partially myelinated cor-
pus callosum (Young et al., 2013). Thus, myelin replacement is
independent of the degree of axon myelination in the structure.
Beside, the authors observed that adult-born OLGs produce more
and shorter internodes (Young et al., 2013). Overall they con-
cluded that most of the new OLGs produced in the adult optic
nerve are engaged inmyelin remodeling, either by replacing dying
OLGs or by adding additional myelin internodes in such a way
that the total number of myelinating cells increases without a
concomitant increase in the total length of myelin sheath (Young
et al., 2013). Another interesting aspect of this analysis is the
demonstration that myelin in the adult brain is thinner (larger
g-ratio) than myelin synthesized in neonate brain (Young et al.,
2013). This analysis could suggest that thinner myelin and shorter
internodes associated with remyelination (see below) might be a
general property of adult myelination rather than a feature of the
regenerative process.
One important step in the future will be to elucidate the
functional consequences of myelin plasticity in the adult brain.
OLIGODENDROGENESIS IN THE DISEASED BRAIN
DISORDERS LEADING TO DEMYELINATION
Apart from well-characterized primary demyelinating diseases
such as multiple sclerosis, demyelination also occurs in a large
variety of CNS insults and pathologies. This is in part due to
high OLG susceptibility to oxidative stress, excitotoxic damage
and inflammatory cytokines, which often go along with trauma,
lesions or infections.
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Basis of oligodendrocyte susceptibility
The intrinsic function of OLGs contributes to their high suscepti-
bility to injuries. Indeed, OLGs show the highest metabolic rates
among all brain cells in order to produce but also to maintain
very high volume of membranes which can represent up to 100
times the weight of the cell (Morell and Toews, 1984). Cell res-
piration in OLGs has been reported to be twice higher than in
neurons (Cammer, 1984). Furthermore, OLGs are paradoxically
poor in gluthatione (Thorburne and Juurlink, 1996) which is a
major anti-oxydant. Thus, OLGs are predisposed to cell death vul-
nerability in conditions of metabolic stress (Connor andMenzies,
1996).
OLGs are also exposed to excitotoxicity since their gluta-
mate receptors are more permeable to calcium (Benarroch,
2009). Glutamate plays major roles in white matter disorders,
for instance its concentration is increased in plaques and nor-
mal appearing white matter of MS patients (Werner et al., 2001;
Srinivasan et al., 2005). In conditions of energy breakdown, rever-
sal of the excitatory amino acid transporters (EAAT) may lead
to glutamate release, contributing to glutamate-induced cytotox-
icity via calcium-triggered NO and O2- synthesis, peroxynitrite
production and finally OLG apoptosis (Benarroch, 2009).
In pathological conditions, activated microglia also contribute
to increase excitotoxicity by secreting glutamate, peroxynitrite
and TNFα (which in turn inhibits EAAT activity and activates
apoptosis) (Li et al., 2005; McTigue and Tripathi, 2008).
Such susceptibility of OLGs partly explains that many patho-
logical situations can affect OLGs and lead to demyelination. In
the following section, we will distinguish demyelination occur-
ing secondary to a pathology that does not primarily target OLGs
and diseases that are considered as true primary demyelinating
diseases.
Demyelination secondary to a primary non-demyelinating pathology
Trauma and ischemia. Primarymechanical damage (strain forces
on tissues, compressions, distortions) is immediately followed
by micro hemorrhages and focal impairment of the cerebral
blood flow that trigger secondary inflammatory and degenerative
processes involving NO, glutamate and free radicals produc-
tion (Carlson et al., 1997; Golding, 2002). Posttraumatic OLG
death has been reported both in animal models (Flygt et al.,
2013) and in postmortem human brains (Shaw et al., 2001). It
is however not always clear whether this is a primary event or
if it is secondary to axonal degeneration. Dynamic of myelin
loss and neuronal death suggest that this could vary depending
on the type of trauma. Similarly, ischemia leads to hypoxia-
induced cell death in the brain. Ischemia occurring in subcor-
tical white matter account for up to 25% of all stroke subtypes
(Bamford et al., 1991; Schneider et al., 2004) and the inci-
dence of such strokes increases with age (Vernooij et al., 2007).
According to the mechanisms of OLG susceptibility described
above, it could be predicted that OLGs would be highly vul-
nerable to ischemia. Indeed, OLG swelling and vacuolization
appear as soon as 3 h after middle cerebral arteria occlusion, fol-
lowed by processes retraction and cell death within 24 h (Pantoni
et al., 2006; McIver et al., 2010). Different studies suggest that
improving remyelination after trauma or ischemia could be an
interesting strategy for improving functional recovery (Plemel
et al., 2014).
Neurodegenerative diseases. Recently, demyelination has also
been associated to a number of neurodegenerative diseases such
as Alzheimer and Huntington, and OLG alterations are observed
across most psychiatric disorders including autism, schizophre-
nia and depression (for review see Edgar and Sibille, 2012).
Analyses from postmortem brain tissue of Alzheimer patients
showed a decrease in the protein levels of MBP, PLP and CNPase
(Vlkolinsky et al., 2001; Roher et al., 2002), together with sig-
nificant regional atrophy of the corpus callosum (Hampel et al.,
1998). More recent studies suggest that white matter abnormali-
ties represent an early feature of Alzheimer (far before neurofib-
rillary tangles and clinical symptoms) and might also contribute
to the pathogenesis of the disease (Sachdev et al., 2013). Indeed,
Aß peptide accumulation probably contributes to white mat-
ter defects since a direct cytotoxic effect on OLGs has been
demonstrated in vitro, with DNA damage, mitochondrial dys-
function and loss of cytoskeleton (Xu et al., 2001; Lee et al., 2004).
Furthermore, a strong correlation between Aß levels and myelin
damage was found in patient’s brains postmortem (Roher et al.,
2002). Detection of white matter abnormalities could thus help to
early diagnosis of Alzheimer’s disease and even be a target for the
development of new therapeutic strategies.
A recent study showing a neuron-to-OLG transfer of abnormal
proteinsmay point to possiblemechanisms leading toOLGs death
in neurodegenerative diseases (Reyes et al., 2014).
Irradiation. Brain irradiation can be useful to treat head and neck
tumors. However, repeated or high doses of radiation may also
have deleterious effects on the central nervous system such as vas-
cular changes and white matter pathology ranging from demyeli-
nation to coagulative necrosis (for review see Valk and Dillon,
1991). Among the described side-effects, radiation-induced optic
neuropathy (Mihalcea and Arnold, 2008) and cognitive dysfunc-
tion (Greene-Schloesser and Robbins, 2012) are serious compli-
cations that can appear during the treatment or in a delayed
manner. Recent study suggests that different white matter fibers
have different sensitivity to radiation, whichmay contribute to the
selective memory and learning dysfunction after brain irradiation
(Nazem-Zadeh et al., 2012).
Viral infection. Progressive multifocal leukoencephalopathy
(PML) occurs in immuno-deficient people and is caused by an
ubiquitous neurotropic virus: the JC virus (for review, see Bellizzi
et al., 2013). PML is mostly found in HIV patients and after grafts
requiring immunosuppressive treatments. PML destroys OLGs,
with intranuclear inclusions, leading to multifocal demyelina-
tion. The symptoms resemble those of multiple sclerosis (see
below), including paralysis, vision loss, impaired speech, and
cognitive deterioration, but the disease usually evolves much
quicker.
Multiple sclerosis: a primary demyelinating disease
Genetic congenital hypomyelinating diseases have been detailed
in a recent review (Perlman and Mar, 2012) and will not be
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treated in this review that focuses more specifically on acquired
demyelinating diseases.
The main primary demyelinating disorder is multiple sclero-
sis (MS) which is a recurrent progressive disease. It is estimated
that approximately 2.5 million people worldwide suffer from MS
(Milo and Kahana, 2010). Most of them are young adults (aged
20–40 years old) with females outnumbering males by 2:1 ratio.
MS is an auto-immune demyelinating and neurodegenerative
disease of the CNS that imposes devastating neurological and psy-
chiatric limits on patients. The specific symptoms are determined
by the location of the demyelinated lesions. They may include
loss of sensitivity, muscle weakness or spasms, ataxia, visual trou-
bles, fatigue, incontinency, but also mood alterations (Compston
and Coles, 2008). The aetiology of the disease is still not well
understood. Both genetic and environmental factors play roles
in the development of the disease (Ramagopalan et al., 2010).
Overall, it has been estimated that changes in the human leuko-
cyte antigen (HLA) system account for between 20 and 60% of
the genetic predisposition (Baranzini, 2011). Environmental fac-
tors and particularly infectious agents that could be linked to
MS have intensively been studied (for review, see Kakalacheva
and Lunemann, 2011). Of all infectious agents, Epstein Barr
virus (EBV) and human herpesvirus 6A have been most strongly
associated with MS (Santiago et al., 2011; Almohmeed et al.,
2013). Clinically, different forms of MS have been characterized
(relapsing-remitting, primary or secondary progressive. . .), lead-
ing sometimes to the suggestion that the term MS could in fact
bring together distinct pathologies, and several studies even chal-
lenge the dogma that auto-immunity is at the root of the disease
suggesting that neurodegeneration could in fact come first (Trapp
and Nave, 2008; Stys et al., 2012).
ANIMAL MODELS OF DEMYELINATION
Although in vitro models also represent useful tools to dissect
mechanisms of myelination and to understand the interactions
between the human immune system and the human CNS, we will
focus here only on in vivo animal models (for review of in vitro
models, see Jarjour et al., 2012; van der Star et al., 2012).
Animal models are rarely the exact counterpart of the human
diseases, especially in pathologies as complex as multiple scle-
rosis, but they are very useful to get insights on the demyeli-
nating/remyelinating processes. Indeed, no single model mimics
all the features of the human disease but each may reflect spe-
cific aspects. Thus, the choice among the multiple demyelinating
models should be determined by the research question.
Animal models of multiple sclerosis may be grossly divided
in two groups: those that try to mimick with highest fidelity the
human disease with its complexity, and those more reduction-
ist that do not reproduce the whole pathogenesis of the disease
but that are used for detailed dissection of specific mechanisms
(Dubois-Dalcq et al., 2005). In the first category, we mainly
find the experimental autoimmune encephalomyelitis (EAE) and
viral models that are considered as clinically relevant models
of MS. These are particularly interesting to study CNS inflam-
mation, to perform pre-clinical safety studies for compounds
targeting immune response and to analyze mechanisms of CNS
viral infection (an encountered side effect of immunosuppressive
treatments in MS patients). On the other hand, these models also
present drawbacks: they induce small, disseminated, demyelina-
tion lesions with unpredictable locations (especially in the brain),
which evolve in an asynchronous manner: demyelination and
remyelination occur simultaneously, rendering difficult the anal-
ysis of temporal cellular and molecular changes. Toxin-induced
demyelination models mainly represent the reductionist models.
They present the advantage of generating reproducible extended
demyelination lesions, with a clear temporal separation between
de- and remyelination processes. They are thus useful to study
specific roles of individual molecules in the repair process, and to
develop strategies to promote remyelination. Since most of them
are not inflammatory, they also allow the study of remyelination
without the action of the adaptative immune system.
EAE and viral models
These models are clinically relevant models of MS character-
ized bymononuclear cell infiltration and demyelination (Traugott
et al., 1986; Boyle and McGeer, 1990). They have been useful
both in the demonstration of T cell-mediated demyelination and
in the characterization of the pathogenesis of immune-mediated
demyelinating disease.
EAE. In contrast to other models, EAE is more versatile and of
purely autoimmune nature, but interestingly key pathological fea-
tures of MS such as inflammation, demyelination, axonal loss and
gliosis are also present in EAE.
EAE can be triggered by two approaches: either an active
immunization using myelin peptides or a passive induction
by adoptive transfer of activated myelin-specific Th1 or Th17
cells from immunized donors into naïve syngeneic recipients
(for technical details see the review of McCarthy et al., 2012).
Inflammation seems to be a more prominent feature than
demyelination in EAE in which only small perivascular demyeli-
nation lesions are observed. The development of a modified
“targeted EAE” model in which focal immune-mediated demyeli-
nation is triggered in a EAE rodent by stereotactic injection of
TNFα in white matter tracts allowed to obtain larger localized and
reproducible demyelination lesions (Kerschensteiner et al., 2004;
Magalon et al., 2007). Another major drawback of the EAEmodel
is the absence of B cell component in the disease process. Indeed,
in MS patients B cells play an important role in the disease and
autoantibodies are detected in blood, CSF and CNS lesions (Link
et al., 1989). However, disease induced in B cell-deficient mice
immunized is indistinguishable from that induced in wild-type
mice (Hjelmstrom et al., 1998). By contrast, Wekerle created a
transgenic mouse spontaneously developing a relapsing/remitting
EAE but that requires the presence of B cells. These mice express
specific T cell receptor for a MOG peptide and drive the produc-
tion of auto-antibodies by endogenous B cells (Pöllinger et al.,
2009).
EAE induction results in the development of an ascending
paralysis. Clinical manifestations are due to a preferential attack
on the spinal cord. The first signs appear 5 to 10 days after induc-
tion as a flaccid tail, then hind limb weakness is observed and
finally paralysis of hind and front limbs. The disease may then
develop into remitting/relapsing form or into a more chronic
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progressive form depending on the mouse strain and the induc-
tion protocol used. Mice that completely recover and remain
stable after the first episode are referred as monophasic. Mice may
also partially recover after the acute phase and keep a handicap
(Batoulis et al., 2011; McCarthy et al., 2012).
EAE can also be used in species closer to humans such as non-
human primates (t Hart et al., 2005). Marmosets and Rhesus
macaque monkeys present the advantage of immunologic and
physiology proximity but also of genetic diversity (outbred ani-
mals) and environmental living conditions (not specific pathogen
free) more representative of the patient population. However,
these aspects can also be considered as disadvantage since they
introduce variability in the experiments and the number of pri-
mates used is generally quite low due to ethical and cost con-
siderations. Nevertheless, these models remain a necessary step
before leading a candidate drug toward clinical trial in human
since several promising compounds identified in rodents showed
no beneficial effects in MS patients.
Viral models. Considering the potential contribution of viral
infections in the etio-pathogenesis of MS (see above), viral mod-
els may provide relevant information on the interactions between
the immune and nervous systems in this pathology. However,
these models are rarely used to dissect mechanisms of remyeli-
nation due to the complex interplay between immune and ner-
vous systems. The most common viral models in rodents are
Semliki Forest virus (SFV), Theiler’s murine encephalomyelitis
virus (TMEV) and mouse hepatitis virus (MHV). Virus may
directly target neurons, thus triggering primary neuron loss and
secondary demyelination (“inside out models” such as TMEV)
or infect OLGs with primary demyelination and secondary axon
loss (“outside in” models such as MHV) or act in an indirect
manner provoking immune-mediated attack of the CNS (Atkins
et al., 2000; van der Star et al., 2012). This is interesting since con-
troversy still exist on the primary nature (neurodegeneration or
demyelination) of the lesions in MS patients (Stys et al., 2012).
Toxin-induced models of demyelination
Stereotaxic injections of gliotoxic compounds such as lysophos-
phatidyl choline (also known as lysolecithin or LPC) and ethid-
ium bromide are widely used to trigger focal demyelination. A
comparative study of these different approaches showed that all
compounds triggered little axonal damage (when the volumes
injected remain small) but large demyelination lesions that under-
went spontaneous remyelination with slightly different kinetics,
remyelination being faster in rats treated with LPC compared to
ethidium bromide (Woodruff and Franklin, 1999).
LPC model. LPC is a membrane-dissolving agent that mainly
affects myelin a structure particularly rich in lipids. Most OLGs
degenerate but OPCs are spared. Injection of 0.5–2μl of 1% solu-
tion in white matter fiber tracts (often performed in spinal cord,
corpus callosum or caudal cerebellar peduncle) triggers an ellip-
soid demyelinated lesion over few mm2. Demyelination can be
observed as soon as 3 days after LPC injection, reaches its maxi-
mum at day 7 and then the remyelination process takes over. The
remyelination is complete after 14–21 days. Although this model
is usually considered as non-inflammatory, it has been shown
that cytokines such as MCP1, MIP1a, and TNFα are secreted
after LPC injection and attract lymphocytes and macrophages
that contribute to demyelination (Ousman and David, 2001).
Injection of LPC in the corpus callosum proximal to the subven-
tricular zone has been a very useful tool to study and demonstrate
the recruitment of SVZ-derived progenitors to the demyelinated
lesion and their contribution to remyelination (Nait-Oumesmar
et al., 1999).
Ethidium bromide. Ethidium bromide is a DNA intercalating
agent therefore it is not specific to OLGs: it also presents a cyto-
toxicity on astrocytes (Blakemore, 1982) and OPCs (Sim et al.,
2002). Ethidium bromide chelates nucleic acids, causes oxidative
stress (Abdel-Salam et al., 2012), and kills cells preserving axons.
Initially used by intracisternal injections (Yajima and Suzuki,
1979), it is now essentially used as focal injections in spinal cord
and cerebellar peduncle. Demyelination is delayed compared to
LPC but lesions are bigger; remyelination is delayed as well, in
part due to a deficit in debris removal in the ethidium bromide
model (Shields et al., 1999). Irradiation (40Gy) has been some-
times used in conjunction with ethidium bromide: it allows the
depletion of endogenous OPCs over larger areas and to exam-
ine the migration potential of OPCs to repopulate the ethidium
bromide-induced demyelinated lesion (Blakemore et al., 2002).
Cuprizone model. By contrast to LPC and ethidium bromide,
Cuprizone is not a focal demyelinating model. Cuprizone is
administered orally in the food and triggers widespread demyeli-
nation in white and gray matters although regional variability is
observed (Skripuletz et al., 2008; Silvestroff et al., 2010; Schmidt
et al., 2013; Steelman et al., 2013). The dose of 0.2% cupri-
zone is admitted to provide the best balance between morbid-
ity and demyelination efficiency (Hiremath et al., 1998). This
model is highly suitable for investigating the remyelination pro-
cess without the influence of the peripheral immune system since
there is no blood brain barrier damage, and it is robust, repro-
ducible with well detectable de- and remyelination processes (for
review see Skripuletz et al., 2011). Its main drawback is that the
mechanisms of actions of cuprizone-induced demyelination are
not well identified. Cuprizone [oxalic acid bis(cyclohexylidene
hydrazide)] is a copper chelator, therefore the leading hypothe-
sis is that cuprizone-induced demyelination is due to deficient
copper concentrations (Benetti et al., 2010). Giant mitochon-
dria are observed in OLGs after cuprizone treatment (Acs and
Komoly, 2012). OLGs being particularly susceptible to altered
energy metabolism, mitochondrial dysfunction could be largely
responsible for cuprizone-induced demyelination. Several stud-
ies reinforced the interest in the cuprizone model by revealing
a mitochondria involvment in both OLG apoptosis and tissue
degeneration in MS (Kalman et al., 2007).
Complete demyelination is observed after 5 weeks of cupri-
zone feeding, however OLG death begins at the end of the first
week already (Mason et al., 2004; Hesse et al., 2010). By contrast,
there is an early increase in the number of microglia and astro-
cytes followed by OPCs proliferation, with a peak at 4.5 weeks
(Matsushima andMorell, 2001). These OPCs start to differentiate
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into newOLGs even if cuprizone is still present (Gudi et al., 2009).
When Cuprizone is stopped after 5 weeks, remyelination is com-
pleted within 2 weeks. However, if cuprizone is maintained on the
long term (up to 12 or 16 weeks), the newly formed OLGs will
be in turn destroyed (Lindner et al., 2009) and even OPCs
will be affected (Mason et al., 2004). In this case, remyelination
will be delayed until 12 weeks after cuprizone removal (Lindner
et al., 2009).
Surprisingly, despite widespread demyelination, no overt neu-
rological signs are detected in cuprizone fedmice. This is probably
due to minimal axon damage in this model (Lindner et al., 2009).
More sophisticated behavioral tests suggested motor coordina-
tion deficits (Liebetanz and Merkler, 2006; Franco-Pons et al.,
2007; Skripuletz et al., 2010) and impairment in spatial working
memory (Makinodan et al., 2009; Xu et al., 2009).
Irradiation
Although irradiation does not directly trigger demyelination, it
kills OPCs (Hinks et al., 2001). Therefore, this approach has
been extensively used in combination to focal demyelination in
order to study remyelination after OPC depletion and to compare
remyelination potential of endogenous vs. transplanted OPCs
(Blakemore et al., 2000a). Fourty Gy irradiation is sufficient
to inhibit endogenous myelin repair (Blakemore and Patterson,
1978), and transplanted OPCs engraft better and contribute
more to myelin repair when endogenous OPCs have been totally
depleted (Irvine and Blakemore, 2007).
Models of ischemia- and trauma-induced demyelination
As mentioned above, apart from primary demyelinating dis-
eases, demyelination also occurs consecutively to trauma or white
mater stroke. Clinical studies showed that atrophy of white mat-
ter tracts and subsequent demyelination is a common occur-
rence in patients with chronic trauma-induced demyelination.
Furthermore, several studies have emphasized the progressive
nature of lesions after white matter injury (Bramlett and Dietrich,
2007; Gouw et al., 2008). Most white matter infarcts are believed
to be secondary to vascular occlusion from changes in small ves-
sels, as well as endothelial cell dysfunction. Few animal models
exist to reproduce traumatic axonal injury or white matter stroke
(Sozmen et al., 2012).
Traumatic axonal injury. Fluid percussion injury in rats has
become the most extensively used animal model to study human
traumatic brain injury producing both focal and diffuse lesions.
However, few studies have focussed on the demyelination aspect
of the lesion. Following moderate fluid percussion on the pari-
etal cortex, OLG number decreases as soon as 3 days after the
lesion in the ipsilateral external capsule and corpus callosum
(Lotocki et al., 2011b). Posttraumatic hypothermia can protect
from OLG death by interfering with caspase3-mediated cell death
mechanisms (Lotocki et al., 2011a), thus hypothermia may be a
therapeutic strategy to protect from demyelination and minimize
functional outcome of traumatic brain injury.
White matter stroke. Two main models are used to either mim-
ick focal white matter strokes (consecutive to acute ischemia or
occlusion of deep penetrating arteriole), or more generalized
white matter disease (induced by dysregulated cerebral blood
flow). This is respectively obtained by focal vasoconstriction
(Hughes et al., 2003) or by artery ligature leading to massive
ischemia (Ni et al., 1994; He et al., 1999). Selective damage of
cerebral white matter has also been achieved using an hypoper-
fusion model in which common carotide arteries are narrowed
by micro-coils (Shibata et al., 2004). Prolonged cerebral hypop-
erfusion triggers reproducible lesions with blood brain barrier
disruption, oxidative stress, glial reactivity and oligodendrocytic
loss. These models may be useful to study the time course of
axonal injury and myelin disruption, and thus to establish critical
therapeutic windows.
Genetic models of acquired demyelination
Several genetic mouse models have been developed to specifi-
cally kill OLGs in order to examine the consequences of primary
OLG death without attack from immune system. The most fre-
quently used systems are the expression of the active form of the
diphteria toxine or its receptor under the control of OLG spe-
cific promotors (MOG, MBP, or PLP) (Buch et al., 2005; Pohl
et al., 2011; Oluich et al., 2012). Altogether these genetic mod-
els show that induction of OLG death in adult mice is followed
by clinical outcome 3–6 weeks postinduction characterized by
spastic paralysis of the hindlimbs, tremor, ataxia, and kyphosis.
At histological and cellular level, progressive myelin vacuolation,
axonal damage and OPCs reactivity were consistently observed,
with partial and heterogenous remyelination. However, although
widespread demyelination is generally described, one study using
a MBP- diphteria toxine receptor mouse together with diphte-
ria toxine injection reported that despite loss of OLG cell bodies
and alterations at the nodes of Ranvier, no overt demyelination
was observed (Oluich et al., 2012). The authors thus suggest that
axonal pathology occurring in the absence of demyelination can
still be secondary to primary pathology of the OLG.
Interestingly, in all these studies despite the presence of myelin
debris no anti-CNS immunity was initiated: no BBB permeabil-
ity nor leukocyte infiltration was detected; by contrast, microglial
activation was present (Pohl et al., 2011; Locatelli et al., 2012;
Oluich et al., 2012). These studies indicate that OLG death per
se does not trigger inflammation in the CNS.
The animal models described above, and more specifically
toxin-induced demyelination models have largely contributed
to our understanding of the demyelination and remyelination
processes.
CHARACTERIZATION OF DEMYELINATION/REMYELINATION
PROCESSES
Spontaneous remyelination
Since the 70’s multiple observations of MS patient’s brain
make up evidence that remyelination can follow demyelination
(Prineas and Connell, 1979; Hirano, 1989; Patrikios et al., 2006).
Remyelination can reach up to 90% in some patients whereas
in others it is sparse and restricted to the marginal zone of the
lesions; no correlation between the extent of myelin repair and
the form or stage of the disease could be established (Patrikios
et al., 2006). An extensive destruction of OLGs is observed in the
Frontiers in Neuroscience | Neurogenesis June 2014 | Volume 8 | Article 145 | 8
El Waly et al. Oligodendrogenesis in the normal and pathological brain
acute MS, despite some preservation in some lesions. However,
in the chronic MS a complete preservation of OLGs in the early
stages and an extensive destruction and loss of OLGs in the late
stages is observed (Ozawa et al., 1994). In later stage, when the
OLGs in lesions suffered an extensive destruction, the remyelina-
tion is restricted to the lesional borders (Ozawa et al., 1994). The
failure of the myelin repair is not only due to OLG loss, but also to
the recurrent episodes of demyelination and inflammation in the
same area. This repetition is considered as one of the most impor-
tant causes of remyelination failure and OPC exhaustion (Prineas
et al., 1993).
Overall, these studies show the existence of spontaneous
remyelination in the human brain, but its efficiency depends on
several factors and conditions such as the lesion location, demyeli-
nation extent, repetition and severity of attacks and genetic
background of the patients.
Morphological evidence of myelin regeneration. Early ground-
breaking electron microscopy studies revealed that regenerated
myelin could be distinguished from normal myelin (Bunge et al.,
1961; Gledhill and McDonald, 1977; Prineas and Connell, 1979;
Blakemore and Murray, 1981; Hirano, 1989). The most obvi-
ous differences are the variations observed in myelin thickness
and internode organization. Indeed, it has been reported that the
g ratio (the fraction of the axonal circumference to the axonal
plus myelin circumference) is increased indicating a reduction in
myelin thickness, and the internode length is decreased during
the regenerative process. During development, myelin thickness
is positively correlated with axon diameter, whereas the thick-
ness of myelin sheath generated during remyelination is reduced
and independent of axon diameter (Fancy et al., 2011). Therefore,
regenerated myelin is easy to recognize for large diameter axons
but more difficult to analyze in small diameter axons such as
in the corpus callosum (Stidworthy et al., 2003). Interestingly, a
recent study challenged this dogma by showing that after a long
delay (6 months), remyelinated axons are indistinguishable from
unaffected axons, except for the largest ones (Powers et al., 2013).
Whether the decrease in myelin thickness is due to a specific
remyelination phenomenon or to an adult myelination property
is an emerging and interesting question. A recent study revealed
that in physiological conditions, the adult-born OLGs produce
thinner and shorter myelin than myelin synthesized at earlier
stage in neonate brain (Young et al., 2013). This observation
suggests that the increase of the g-ratio in the remyelination is
correlated with a specific property of the adult myelination.
Contribution of parenchymal OPCs to spontaneous remyelina-
tion. Following demyelination, most OLGs are eliminated and
the few remaining ones do not appear to divide (Keirstead and
Blakemore, 1997; Carroll et al., 1998), suggesting that they prob-
ably do not contribute to myelin repair. By contrast, many studies
demonstrated the early reaction of OPCs following demyeli-
nation, showing proliferation and colonization of the lesion
(Franklin et al., 1997; Levine and Reynolds, 1999; Blakemore
et al., 2000b; Chari and Blakemore, 2002a). During remyelina-
tion, OLGs density increases at the expense of OPCs number, sug-
gesting that reactive OPCs finally differentiate into myelinating
OLGs. Genetic tracing finally provided the absolute proof of OPC
contribution to myelin repair. Using PDGFRα-CreERT2 mice,
Franklin’s laboratory demonstrated that adult OPCs generate
myelinating OLGs after toxin-induced demyelination (Zawadzka
et al., 2010).Myelinating Schwann cells were also observed in CNS
during the repair process (for review, see Zujovic et al., 2010).
However, genetic lineage tracing revealed that most Schwann
cells generated after demyelination were produced by OPCs
(Zawadzka et al., 2010). Thus, in the adult central nervous system,
OPCs represent the main source of cells for myelin repair.
Activation of parenchymal OPCs does not occur only after pri-
mary demyelinating lesions, but also consequently to any insult
leading to secondary demyelination including trauma (Flygt et al.,
2013) or consecutive to amyloid plaque deposition in Alzheimer’s
disease (Behrendt et al., 2013) (see above § Demyelination sec-
ondary to a primary non-demyelinating pathology). OPC acti-
vation requires their exit from quiescence, their proliferation
and migration toward the lesion. The migration and repopula-
tion by OPCs is slow, especially if large areas depleted in OPCs
are present (for instance in the EB plus irradiation model, see
above). In such case, interaction between OPCs and demyelinated
axons is delayed and remyelination is less efficient, suggesting
that the environment of the acutely demyelinating tissue provides
the support required to achieve successful terminal differenti-
ation (Blakemore et al., 2002). Indeed, many studies revealed
that inflammatory cues play important role in OLG regeneration
and remyelination (Arnett et al., 2001; Kotter et al., 2001; Bieber
et al., 2003; Li et al., 2005). This led to propose the temporal
mismatch hypothesis according to which non-remyelinated MS
lesions exist because OPCs are destroyed during the destructive
phase leading to wide areas devoided of OPCs. Since the repopu-
lation of OPC depleted tissues is slow, OPCs reach demyelinated
axons in a delayed time-window when inflammatory cues nec-
essary to promotes OPC reactivation and differentiation have
disappeared (Blakemore et al., 2002; Chari and Blakemore,
2002b).
Contribution of SVZ-derived progenitors to spontaneous
remyelination. Recently, studies revealed that SVZ-derived
progenitors also contribute to myelin repair. Menn and col-
laborators were the first to bring formal demonstration of the
oligodendrogenic potential of SVZ stem cells (Menn et al., 2006).
In physiological condition, a small subpopulation of type C
cells in the SVZ express Olig2 and PDGFRα. These SVZ-derived
OPCs migrate to the corpus callosum and form mature OLGs
(Menn et al., 2006). After demyelination insult this potential is
four-fold increased suggesting a role for SVZ-derived OPCs in
myelin repair (Menn et al., 2006). The first indication of SVZ
contribution to myelin repair was provided by the observation
of ectopic migration of neuroblasts from SVZ to periventricular
white matter in LPC and EAE models (Nait-Oumesmar et al.,
1999; Picard-Riera et al., 2002). A recent study has shown that
vascular remodeling after acute demyelination lesion in the
corpus callosum favors the exit and migration of neuroblasts
from their niche to the lesion site, blood vessels acting as
migratory scaffold for ectopic migrating progenitors (Cayre
et al., 2013). The oligodendrogenic potential of neuroblasts was
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corroborated by grafting experiments showing that purified SVZ
neuroblasts transplanted in the corpus callosum of shiverer mice
(mice lacking MBP expression) massively generate myelinating
OLGs (Cayre et al., 2006). Finally genetic tracing studies using
DCX-CreERT2 mice provided the proof of this endogenous
lineage plasticity from neuronal to oligodendrocytic fate after
demyelination insult and unveiled the role of Chordin in this
process (Jablonska et al., 2010).
The human sub-ventricular zone of the lateral ventricles con-
tains a ribbon of astrocytes, self-renewal and multipotential cells
(Sanai et al., 2004). These stem cells and their progeny present
similarities with those of rodents: they express the same mark-
ers such as glial fibrillary acidic protein (GFAP), nestin, the
polysialylated form of the neural cell adhesion molecule (PSA-
NCAM) and the epidermal growth factor receptor (Bernier et al.,
2000; Weickert et al., 2000). In MS patients, SVZ reactivity
(increased cell proliferation and density) has been observed asso-
ciated with the presence of neuronal progenitors with migratory
phenotype (Nait-Oumesmar et al., 2007). Furthermore, some of
these neuronal progenitors (PSA-NCAM+) also expressed oligo-
dendrocytic marker such as Olig2 and Sox10 (Nait-Oumesmar
et al., 2007). These triple labeled cells were more frequent
in periventricular lesions than in more remote lesions (Nait-
Oumesmar et al., 2007), suggesting that SVZ contribution
to myelin repair together with lineage plasticity observed in
rodents may also be at play in humans. It is thus impor-
tant to characterize the mechanisms regulating this process in
order to develop new therapeutic strategies promoting remyeli-
nation. Interestingly, the therapeutic potential of SVZ-derived
NSCs in MS is not restricted to cell replacement. These cells
also play beneficial role through immunomodulation: they reg-
ulate inflammatory processes and thus present neuroprotec-
tive properties favoring regeneration (Pluchino et al., 2003,
2009).
Factors controling remyelination
Spontaneous remyelination can be influenced by physiological
factors such as aging, exercice and enriched environment. Aging
has been shown to inhibit the efficiency of the process, mainly
delaying OPC recruitment and differentiation (Shields et al.,
1999; Sim et al., 2002). The age-dependent decrease in spon-
taneous myelin repair in rodents has been attributed both to
intrinsic properties of aging OPCs, for instance decrease in CREB
signaling (Miyamoto et al., 2013), and impaired response of
macrophages (Zhao et al., 2006) and monocytes (Ruckh et al.,
2012) to demyelination, the presence of myelin debris inhibit-
ing OPC differentiation (Kotter et al., 2006; Ruckh et al., 2012).
To note, a large-scale analysis of postmortem MS patient brains
paradoxically did not find any correlation between the age at
disease onset and the extent of remyelination (Patrikios et al.,
2006). Exercise and enriched environment have been shown to
reduce functional impairment in EAE mice, to increase SVZ
mitotic activity and SVZ-derived progenitor mobilization toward
demyelinated lesions, and finally to promote the OLG fate of
recruited progenitors (Magalon et al., 2007). Interestingly, mod-
erate physical activity improves functional outcomes in MS
patients (Petajan and White, 1999).
Identifying factors and signaling pathways involved in myelin
repair and notably in OPC determination, proliferation, migra-
tion or maturation is essential for a deeper understanding of these
processes and the development of new therapies. Several lines
of evidence highlight the potential role of secreted and contact
mediated factors on demyelination and remyelination processes
(Table 1).
Secreted factors.
Growth factors. Fibroblast growth factor 2 (Fgf2) is expressed
in the adult SVZ and plays a major role in the maintenance of
NSCs (Zheng et al., 2004). Both Fgf2 and Fgf receptor 1 are
up-regulated in the corpus callosum during cuprizone-induced
demyelination and expressed by OLGs prior to remyelination
(Zhou et al., 2012). Manipulations of Fgf expression or its sig-
naling pathway affect multiple steps of the repair process. In
viral (Frost et al., 2003), compressive (Whittaker et al., 2012)
or cuprizone (Armstrong et al., 2002) induced demyelination,
Fgf2 acts as a mitogen activating the proliferative response of
OPCs. Fgf2 has been shown to trigger opposite effects on OLGs
maturation depending on the model; while it favors OLG mat-
uration following LPC induced demyelination of the optic chi-
asma (Dehghan et al., 2012) it blocks it in cuprizone and viral
induced demyelination (Armstrong et al., 2002). The effect of
Fgf on functional recovery also depends on the model, for exam-
ple in EAE, Fgf reverts the clinical course and the pathological
signs suggesting a neuroprotective effect (Ruffini et al., 2001;
Rottlaender et al., 2011) while in cuprizone mouse model the
presence of Fgf is associated with an increase in axonal damage
(Tobin et al., 2011) and decrease in functional recovery (Mierzwa
et al., 2013). In vitro analyses have also shown an effect of FGF
on OPCs directed migration (Zhang et al., 2004; Biname et al.,
2013) but no analysis have confirmed this result in vivo during
demyelination.
Epidermal growth factor (Egf) can also induce proliferation
of adult stem cells and neural progenitors in the adult brain
(Doetsch et al., 2002). Over expression of this growth factor or
its receptor confers new migratory properties to postnatal neu-
ral progenitors in the SVZ (Aguirre et al., 2005, 2007; Cantarella
et al., 2008). In pathological condition, overexpression of human
Egfr in OLG lineage cells or the administration of intranasal
heparin-binding Egf immediately after injury has been shown
to decrease oligodendroglia death, enhance generation of new
OLGs from parenchymal OPCs and promote functional recovery
(Scafidi et al., 2014). Intranasal heparin-binding Egf administra-
tion can also significantly increase SVZ cell proliferation and pro-
genitor mobilization toward the lesions following LPC-mediated
demyelination (Cantarella et al., 2008).
Neuregulin1 (Nrg-1) also signals through the EgfR ErbB.
During development, Nrg-1-ErbB signaling is a key regulator of
axon ensheathment and myelin thickness, regulating OLG differ-
entiation, survival, maturation, andmyelination (Kim et al., 2003;
Brinkmann et al., 2008; Taveggia et al., 2008). In demyelination
context, administration of Nrg-1 promotes functional recovery in
acute and relapsing phases of EAE through the establishment of
a more favorable immune environment (Cannella et al., 1998).
In the same line, a significant increase in the number of newly
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Table 1 | Factors controlling the various steps of the regenerative process in mouse models of demyelination.
FACTORS Survival Proliferation Migration Maturation Functional recovery
GROWTH FACTORS
FGF2 Frost et al., 2003
Whittaker et al., 2012
Armstrong et al., 2002
Zhang et al., 2004
Biname et al., 2013
Dehghan et al., 2012
Armstrong et al., 2002
Ruffini et al., 2001
Rottlaender et al., 2011
Mierzwa et al., 2013
EGF Scafidi et al., 2014 Cantarella et al., 2008
Aguirre et al., 2007
Cantarella et al., 2008
Aguirre et al., 2005, 2007
Scafidi et al., 2014
Nrg-1 Gauthier et al., 2013 Gauthier et al., 2013 Cannella et al., 1998
NEUROTROPHIC FACTORS
BDNF+NT3 McTigue et al., 1998
Girard et al., 2005
Girard et al., 2005 Girard et al., 2005
PDGF Murtie et al., 2005
Woodruff et al., 2004
Zhang et al., 2004
GUIDANCE CUES
Semaphorins Piaton et al., 2011
Piaton et al., 2011
Syed et al., 2011
Reelin Courtes et al., 2011 (SVZ)
Netrin1 Cayre et al., 2013 (SVZ)
CYTOKINES
TNFα Arnett et al., 2001 Arnett et al., 2001 Selmaj et al., 1991, 1995
LIF Butzkueven et al., 2002
Kerr and Patterson, 2005
Marriott et al., 2008
Deverman and Patterson,
2012
Marriott et al., 2008
Deverman and Patterson,
2012
CNTF Vernerey et al., 2013
(SVZ)
Vernerey et al., 2013 Tanaka et al., 2013
CXCL1 Hosking et al., 2010 Kerstetter et al., 2009 Kerstetter et al., 2009 Kerstetter et al., 2009
CXCL12 Patel et al., 2010 Patel et al., 2010
MORPHOGENS
Shh Ferent et al., 2013 Ferent et al., 2013
Bambakidis et al., 2003
Ferent et al., 2013
BMP Jablonska et al., 2010 Dizon et al., 2011
Cate et al., 2010
Dummula et al., 2011
Ara et al., 2008
Wnt Fancy et al., 2009
HORMONES
IGF1 Mason et al., 2001, 2003 Mason et al., 2001
T3 Harsan et al., 2008 Harsan et al., 2008 Harsan et al., 2008
RXR-g Huang et al., 2011
CELL/ECM COMMUNICATION
Integrins Stoffels et al., 2013
CSPG Lau et al., 2012
Siebert et al., 2011
CELL/CELL COMMUNICATION
Notch-1 Aparicio et al., 2013
Zhang et al., 2009 (SVZ)
Zhang et al., 2009
Hammond et al., 2014
Seifert et al., 2007
Lingo-1 Mi et al., 2007, 2008,
2009
Jepson et al., 2012
Mi et al., 2007, 2009
PSA-NCAM Nait-Oumesmar et al.,
1999
Koutsoudaki et al., 2010
References in green or in red indicate that the factor has respectively a positive or negative impact on the cellular processes or on functional recovery.
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formed OLGs was observed following SC injury upon Nrg-1
treatment (Gauthier et al., 2013).
Collectively, these data suggest that EgfR signaling promotes
the various steps of the repair process and functional recovery.
Neurotrophic factors. NGF, BDNF, neurotrophin-3, 4, and 5 and
their receptors influence myelin formation via two distinct mech-
anisms, either by acting on the neurons, changing the axonal
signals that control myelination, or by acting directly on OLGs
(Cellerino and Kohler, 1997; Wong et al., 2013). Several studies
provide evidence that neurotrophins are effective positive regu-
lators of remyelination and functional recovery after SC injury
(McTigue et al., 1998; Girard et al., 2005). Transplantation of
fibroblasts or Schwann cells expressing BDNF, GDNF, or NT-3
into demyelinated rodent SC enhances axonal growth, remyeli-
nation and locomotor recovery (McTigue et al., 1998; Blesch and
Tuszynski, 2003; Girard et al., 2005). BDNF and NT3 in this con-
text were shown to specifically stimulate OPC proliferation and
differentiation (McTigue et al., 1998; Girard et al., 2005). PDGF-A
has been shown to control OPC proliferation during the early
phase of the regenerative process in LPC and cuprizone induced
demyelination whitout favoring remyelination (Woodruff et al.,
2004; Murtie et al., 2005).
Guidance cues. During development, the secreted class 3
semaphorins, Sema3A, and Sema3F, are known to have opposite
effects on OPC migration: repulsive and attractive, respectively
through distinct neuropilin co-receptors (NRP1 for Sema3A and
NRP2 for Sema3F) (Sugimoto et al., 2001; Spassky et al., 2002).
Sema3A and 3F and their receptors are up regulated in OPCs
following LPC-induced demyelination. The lentiviral-mediated
overexpression of Sema3F by astrocytes in and around the lesion
increases OPC density within the lesion (Piaton et al., 2011) while
the overexpression of Sema3A leads to an impaired OPC recruit-
ment toward the demyelinated area thus preventing remyelina-
tion (Piaton et al., 2011; Syed et al., 2011). Reelin and Netrin1,
two developmental guidance cues, are both upregulated after
LPC induced demyeliation and promote SVZ-derived progeni-
tor migration toward the lesion (Courtes et al., 2011; Cayre et al.,
2013). Altogether, these results support a role of guidance cues in
the repair process by regulating progenitor migration in the early
phase of the regenerative process.
Cytokines. In CNS, cytokines exhibit critical role in repair
processes by mediating inflammatory responses that pro-
mote pathogen clearance and prevent excessive tissue damage.
However, their overproduction may lead to high inflammation
and cell death (Mason et al., 2001). Interestingly, it is now clearly
demonstrated that cytokines have a positive impact on the repair
process.
Several studies have shown that the overexpression of TNFα
worsens the demyelination in EAE mouse model (Selmaj et al.,
1995) while the administration of anti-TNFα neutralizing anti-
bodies has a protective effect (Selmaj et al., 1991; Selmaj and
Raine, 1995). Despite this deleterious effect, some of these
cytokines have been shown to have positive impact during
remyelination phases by acting directly on OLGs (see Table 1).
For example, administration of cuprizone to TNFα knockout
mice leads to a significant delay in remyelination by decreasing
the pool of proliferating OPCs and their maturation into OLGs
(Arnett et al., 2001). This result clearly indicates a positive effect
of TNFα during the repair process.
In the family of neurotrophic cytokines, ciliary neurotrophic
factor (CNTF) and leukemia inhibitory factor (LIF) share some
common protective roles in axons and oligodendrocytes. LIF
exerts protective functions on oligodendrocytes and regulates
positively many steps of the repair process (Butzkueven et al.,
2002; Kerr and Patterson, 2005; Marriott et al., 2008; Deverman
and Patterson, 2012). Beside its well-known neuroprotective
action (Linker et al., 2009, 2002) CNTF has been shown to control
directed cell migration during endogenous progenitor mobiliza-
tion after demyelination (Vernerey et al., 2013). CNTF is strongly
re-expressed around the lesion and acts as a chemoattractant on
both SVZ derived progenitor and OPCs favoring their migration
toward demyelinated areas (Vernerey et al., 2013). A distinct study
has shown that decreased CNTF expression leads to OPC mat-
uration defects after cuprizone-induced demyelination (Tanaka
et al., 2013). Altogether, these results suggest that CNTF could
positively regulate various steps of the regenerative process by
promoting cell migration, proliferation and OLGs maturation.
CXCL1 and CXCR2 are detected in the SC in viral (Hosking
et al., 2010) and autoimmune (Omari et al., 2009) demyelination
models. Blocking CXCR2 results in an enhanced viral-induced
demyelination associated with OLG death within the white mat-
ter tracts of the SC (Hosking et al., 2010). However, opposite
results were obtained after chemical inhibition of CXCR2 either
in EAE or LPC mouse model of demyelination (Kerstetter et al.,
2009). In this context, the neutralization of CXCR2 significantly
reduces lesion size and enhances remyelination suggesting that
CXCR2 can also negatively influence remyelination in pathologi-
cal context (Kerstetter et al., 2009). In cuprizone mouse model,
CXCL12 (also named SDF-1) another chemokine secreted by
astrocytes and microglia enhances both OPC mobilization and
maturation within the corpus callosum (Patel et al., 2010). These
findings support a dual role of cytokines in myelin repair fol-
lowing demyelination. It could be explained by the involvement
of some cytokines and their receptors, such as CXCR2, in neu-
roinflammatory events acting on both hematopoietic and neu-
ral cells in inflammatory models of demyelination (Liu et al.,
2010).
Morphogens. Sonic hedgehog. In the adult brain, Shh signaling
is present (Traiffort et al., 1999; Coulombe et al., 2004) and
required for the maintenance of stem cells niches (Charytoniuk
et al., 2002) and migration of neuroblasts (Angot et al., 2008).
The number of proliferating progenitors can be increased upon
administration of Shh proteins in the cerebral cortex, corpus cal-
losum (Loulier et al., 2005) and in the SC after injury (Bambakidis
et al., 2003). Shh signaling pathway actors are expressed during
the onset of demyelination in LPC induced demyelination (Ferent
et al., 2013). In this context, Shh treatment increases the number
of OPCs and mature myelinating OLGs at the lesion due to an
enhanced proliferation, survival, and differentiation of the resi-
dent OPCs. Conversely, blocking Shh activity leads to a decrease
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of OPC proliferation and differentiation preventing repair (Ferent
et al., 2013).
Bone morphogenetic proteins. Several studies have clearly demon-
strated the implication of BMP signaling in healthy (Colak
et al., 2008) and in demyelinated adult brain (Cate et al.,
2010; Jablonska et al., 2010). Previous work in EAE model
showed a correlation between the up-regulation of BMP sig-
naling (BMP4, 6, and 7) in the SC and disease severity (Ara
et al., 2008). The infusion of Noggin or chordin (BMP sig-
naling inhibitors) increases SVZ cell commitment to OLG lin-
eage and their mobilization in corpus callosum following LPC
(Jablonska et al., 2010) or cuprizone (Cate et al., 2010) demyeli-
nation. Furthermore, BMP signaling decreases OLG maturation
following perinatal hypoxic-ischemic brain injury (Dizon et al.,
2011) or intraventricular hemorrhage (Dummula et al., 2011).
Altogether these data indicate that BMP acts as a negative reg-
ulator of myelin repair by preventing cell mobilization and
maturation.
Wnt/β-catenin/Tcf4 signaling pathway.During development, Wnt
and BMP signaling pathways are known to have similar inhibitory
effects on OLG differentiation (See and Grinspan, 2009). In this
context, appearance of mature OLGs is delayed in mice in which
Wnt/beta-catenin signaling is constitutively activated in OLGs.
The transcription factor Tcf4, a mediator of Wnt signaling, has
been shown to be expresssed within remyelinating lesions after
LPC injection in the SC indicating activation of the Wnt pathway
in the lesion (Fancy et al., 2009). Moreover, the overexpression
of β-catenin in the OLGs induces a delay in OPCs differentia-
tion and impaired remyelination in LPC model. Altogether, these
experiments show that theWnt/β-catenin/Tcf4 signaling pathway
represents a negative regulator of remyelination.
Hormones. Various hormones have been shown to have benefi-
cial effect on the repair process. Insulin growth factor-1 (IGF1) or
triiodothyronine (T3)-treated mice exhibit enhanced OPC pro-
liferation and survival after cuprizone intoxication (Mason et al.,
2000, 2003; Harsan et al., 2008). T3 treatment leads to acceler-
ated functional recovery (Harsan et al., 2008). The retinoid acid
receptor RXR-γ is expressed during remyelination and its down
regulation delays OLG differentiation and myelin repair (Huang
et al., 2011). These examples suggest that treatments targeting
hormones or their receptors could be valuable tools to promote
remyelination.
In summary, secreted factor including growth factors, neu-
rotrophins, morphogens, hormons and steroids (seeTable 1) have
been shown to have individual effects on remyelination by act-
ing on one or several steps of the repair process. In the context of
myelin repair, numerous studies have addressed the effect of com-
bination of factors. For example a cocktail of factors including
PDGFaa, bFGF, NT3, and IGF1 can increase OPC proliferation
and migration in cuprizone induced demyelination (Kumar et al.,
2007). EGF, bFGF and PDGFaa administration in SC after injury
could promote the activation and oligodendroglial differentia-
tion (Karimi-Abdolrezaee et al., 2012). Sequential administration
of factors could represent a promising therapeutic strategy to
regulate specific steps of the repair process. This is still an open
field of investigation.
Contact-mediated factors.
Cell/extracellular matrix (ECM) communication. Ligands/
integrins complex are known to play a critical role in white mat-
ter development by promoting survival of newly formed OLGs
that establish appropriate contacts with axons to be myelinated
(Colognato et al., 2002). Almost all ligands for these αV Integrins
including TenascinC and R, Fibronectin, and Vitronectin are
transiently up regulated within demyelinated areas following
toxin (LPC or EB)-induced demyelination (Zhao et al., 2009).
Fibronectins are reported to inhibit OLG differentiation and
remyelination in toxin-induced demyelination models (Stoffels
et al., 2013). Interestingly, the overexpressed Fibronectin remains
predominantly soluble following toxin-induced demyelination
while aggregated forms of the Fibronectin are observed in EAE
animals where remyelination often fails (Stoffels et al., 2013).
These findings suggest that Fibronectin aggregation is mediated
by inflammatory events and plays a critical role in the negative
impact of this ECM.
Chondroitin and keratan sulphate proteoglycans represent the
main inhibitory ECM molecules produced by reactive astro-
cytes in the glial scar following brain or SC injury (Fitch and
Silver, 1997). An early and robust up-regulation of Chondroitin
sulphate proteoglycan (CSPGs) was observed following LPC-
induced SC demyelination (Lau et al., 2012). Moreover, the
modulation of the CSPG synthesis or activity promotes the
endogenous OPC recruitment toward the lesion site either in
LPC-induced SC demyelination (Lau et al., 2012) or after SCI
(Siebert and Osterhout, 2011; Siebert et al., 2011). These data
suggest that, beside their positive effect in regenerative axonal
sprouting, CSPGs located in the postinjury environment have a
dual action, acting as a negative regulator of myelin repair by
limiting OPC migration (Siebert et al., 2011).
Cell/cell communication. Notch. During development, the acti-
vation of Notch signaling was reported to have an inhibitory
effect on OPC differentiation and myelination in vitro and in vivo
(Wang et al., 1998; Givogri et al., 2002; Zhang et al., 2009). Notch1
is expressed by OPCs within lesions that undergo complete
remyelination in SC of EAE animals (Seifert et al., 2007). Notch
signaling is also detected in neural progenitors (Nestin+) and
OPCs both in the SVZ and corpus callosum of LPC-demyelinated
rats (Aparicio et al., 2013). Specific inactivation of Notch1 in
OPCs in LPC-induced demyelination restricts OPC expansion
and potentiates maturation and myelination (Zhang et al., 2009;
Hammond et al., 2014). Nevertheless, another study got to a
different conclusion following cuprizone-induced demyelination
(Stidworthy et al., 2004). In this context, Notch1 depletion did
not lead to any significant difference in remyelination parame-
ters. Possible key difference in these findings could be the use of
distincts Cre driver or the demyelination models used.
LINGO-1. LINGO-1 is a transmembrane signaling protein
expressed by both neurons and OLGs. By using different strate-
gies leading to the loss of LINGO-1 function, including Lingo1
gene knockout, infusion LINGO-1 antagonist (LINGO-1-Fc) and
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LINGO-1 si-RNA,Mi and collaborators have shown that LINGO-
1 is an important negative regulator of myelination during devel-
opment (Mi et al., 2005, 2008) and that its down regulation is
important to control the timing of myelination onset during the
repair process (Mi et al., 2007, 2009). A recent analyse has shown
that LINGO-1 acts as both a ligand and a receptor and that
the mechanism by which it negatively regulates OPC differenti-
ation and myelination is mediated by a homophilic intercellular
interaction. Disruption of this protein-protein interaction could
lead to a decrease of LINGO-1 inhibition and an increase in
myelination (Jepson et al., 2012). Consistent with these observa-
tions, an improved functional recovery was observed in LINGO-1
knock-out in the three main mouse models of demyelination
(LPC, Cuprizone, and EAE) (Mi et al., 2009). Altogether, these
data suggest a central role for LINGO-1 in orchestrating myelin
repair acting as a negative regulator of OLG differentiation and
myelination.
PSA-NCAM. During development, the polysialylated form
of the neural cell adhesion molecule (PSA-NCAM) acts as
an inhibitor of myelination, presumably by preventing myelin-
forming cells from attaching to the axon (Doherty et al., 1990;
Charles et al., 2000; Fewou et al., 2007). In the adult brain,
PSA-NCAM expression is maintained in areas showing plastic-
ity such as the SVZ (Durbec and Cremer, 2001; Rutishauser,
2008). Interestingly, previous studies have shown a transient
re-expression of PSA-NCAM on myelinating precursor cells dur-
ing their recruitment to demyelinated lesions in LPC-induced
demyelination, which ceases when myelin repair was accom-
plished (Nait-Oumesmar et al., 1999). In vitro data have suggested
that PSA-NCAM could be specifically involved in establishing the
directionality of OPC migration in response to a concentration
gradient of PDGF (Zhang et al., 2004). In vivo, the deletion of
St8siaIV, one of the two polysialyltransferases enzymes respon-
sible for the PSA synthesis, leads to an earlier remyelination in
cuprizone mouse model (Koutsoudaki et al., 2010). These data
suggest that PSA-NCAM could favor the mobilization of OPCs
during early phase of the repair process but then would acts as an
inhibitory signal for OPC differentiation.
From bench to bed
Despite recent progress in treating the inflammatory component
of MS, current therapies have no clear impact on progression of
disability related to myelin and axon injury. As described above,
various factors can specifically regulate the cellular processes
involved in remyelination including OPC migration, survival
and proliferation and OLG maturation. Among these factors,
those that have been shown to control OPC differentiation and
could regulate the late phase of the repair process have received
considerable attention and some are now promising candidate
medicaments. For example, one approach currently in phase
1 clinical trial is the use of a neutralizing antibody targeting
LINGO-1 since antagonism of LINGO-1 promotes OPC differ-
entiation and leads to remyelination in mouse models of MS
(Mi et al., 2007, 2009, 2013). Another promising candidate is
olesoxime, a derivative of cholesterol shown to promote OLG
maturation and myelin repair in animal models (Magalon et al.,
2012). This compound is currently under phase 2 clinical trial
for MS. The sphingosine-1-phosphate (S1P) receptor agonist,
fingolimod (FTY720, Novartis) is in late stages of clinical devel-
opment and may soon be approved to treat MS patients. This
compound, beside its immunomodulating effect (Kataoka et al.,
2005), has been shown to modulate S1P receptor activity promot-
ing both OPC survival and OLG maturation (Jung et al., 2007;
Miron et al., 2008). Altogether these compounds could represent
future medicaments to favor myelin regeneration in human.
CONCLUSION
Our knowledge of oligodendrogenesis has a great deal evolved
over these past 10 years, with increasing number of research
teams getting interested in postnatal production of OLGs and
myelin repair. Interestingly, progenitor cells including parenchy-
mal OPCs and SVZ cells represent more than 5% of the total cell
number in the adult brain parenchyma. Such an important pool
of progenitors may relate to high plasticity properties. Indeed, as
mentioned in this review, oligodendrogenesis carries on through-
out life, contributing to myelination and/or myelin remodeling,
a process that may be important for functional plasticity, learn-
ing and memory. In parallel, many OPCs remain as quiescent or
cycling very slowly progenitors, but with the ability to reactivate as
soon as a demyelination insult occurs. Spontaneous myelin repair
is therefore a strikingly common event, very efficient in most
rodent models of demyelination, but quite variable in human
patients suffering from autoimmune disease such as MS. The
interplay between immune and nervous system is very complex
in this pathology; inflammation acts like doctor Jekill and Mr.
Hide: it is necessary to trigger OPC mobilization and differentia-
tion, but deleterious for cell survival when it is prolonged. Because
of this prevalent inflammatory component, existing treatments
mainly exclusively target inflammation, with low efficiency on the
progression of invalidity on the long-term. Neuroprotection, and
thus remyelination needs to be promoted in conjunction to these
treatments. A better knowledge of all the cell populations and
factors involved in the repair process will undoubtedly allow the
development of new therapeutic strategies.
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